Capricor (CAPR) 2025 Earnings: What Investors Should Know
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesCapricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
BitGo expands institutional access by enabling OTC entry to prediction markets through a new alliance with Susquehann...
An 8% year rise in a regulated water utility stock and a major investor trimming a $28 million stake highlight how to...
May brings optimism for growth investors. In this guide, I share my favorite growth stocks to buy in May, why they fi...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Nvidia just increased holding in a high-growth AI stock that has climbed nearly 50% this year. This article breaks do...
A deep dive into the IPO prospectus reveals practical lessons every investor should know. Here are more things learne...
Two very different computer vision players sit at automation's frontier. This guide weighs Aeva Technologies and Cogn...
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
A promising AI-driven play could redefine long-term portfolios. Learn why this stock might be a once-in-a-decade inve...
Alphabet is now part of the Dow, a milestone that goes beyond a headline. This shift has implications for index desig...